Atlas Trials

Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors

Clinical trial NCT01619865 · COMPLETED

Trial details

NCT number
NCT01619865
Sponsor
Sue O'Dorisio
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorsCarcinoid TumorsNeuroblastomaMedulloblastoma
Start date
2012-02-21
Primary completion
2017-08-27
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.